Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private

BSE1439.6030.7 (+2.18 %)

PREV CLOSE ( ) 1408.90

OPEN PRICE ( ) 1419.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5987

TODAY'S LOW / HIGH ( )1406.60 1465.50

52 WK LOW / HIGH ( )890 1524.85

NSE1438.6029.3 (+2.08 %)

PREV CLOSE( ) 1409.30

OPEN PRICE ( ) 1409.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1438.60 (3)

VOLUME 177399

TODAY'S LOW / HIGH( ) 1408.00 1469.00

52 WK LOW / HIGH ( )889 1519.9

Chairman	Berjis Desai
Managing Director	Satish Mehta
Non Executive Independent Director	PS Jayakumar Vijay Gokhale Shailesh Ayyangar Vidya Yeravdekar
Whole Time Director	Sunil Mehta Mukund Gurjar Namita Thapar Samit Satish Mehta

Incorporation Year : 16-04 1981

Registered Office :

Address : Plot No. P-1 & P-2,I T - B T Park, Phase- I I,M I D C, Hinjawadi Pune,
Maharashtra-411057 .

Phone : 020-35070033 / 35070000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE